{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:25:44Z","timestamp":1794576344082,"version":"4.9.1"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1038\/s41569-026-01301-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:15:55Z","timestamp":1781784955000},"page":"877-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitochondrial cardiomyopathy: bridging molecular mechanisms and clinical frontiers"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-2881","authenticated-orcid":false,"given":"Atsuko","family":"Imai-Okazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-0333","authenticated-orcid":false,"given":"Liming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-8278","authenticated-orcid":false,"given":"Douglas C.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1093\/eurheartj\/ehae421","volume":"45","author":"LR Lopes","year":"2024","unstructured":"Lopes, L. R., Ho, C. Y. & Elliott, P. M. Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice. Eur. Heart J. 45, 2727\u20132734 (2024).","journal-title":"Eur. Heart J."},{"key":"1301_CR2","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/JCI120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou, B. & Tian, R. Mitochondrial dysfunction in pathophysiology of heart failure. J. Clin. Invest. 128, 3716\u20133726 (2018).","journal-title":"J. Clin. Invest."},{"key":"1301_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1988","unstructured":"Wallace, D. C. et al. Mitochondrial DNA mutation associated with Leber\u2019s hereditary optic neuropathy. Science 242, 1427\u20131430 (1988).","journal-title":"Science"},{"key":"1301_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/331717a0","volume":"331","author":"IJ Holt","year":"1988","unstructured":"Holt, I. J., Harding, A. E. & Morgan-Hughes, J. A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331, 717\u2013719 (1988).","journal-title":"Nature"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng0797-226","volume":"16","author":"BH Graham","year":"1997","unstructured":"Graham, B. H. et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart\/muscle isoform of the adenine nucleotide translocator. Nat. Genet. 16, 226\u2013234 (1997).","journal-title":"Nat. Genet."},{"key":"1301_CR6","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1073\/pnas.1300690110","volume":"110","author":"KA Strauss","year":"2013","unstructured":"Strauss, K. A. et al. Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup. Proc. Natl Acad. Sci. USA 110, 3453\u20133458 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1301_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.mito.2010.02.003","volume":"10","author":"S Tang","year":"2010","unstructured":"Tang, S., Batra, A., Zhang, Y., Ebenroth, E. S. & Huang, T. Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion 10, 350\u2013357 (2010).","journal-title":"Mitochondrion"},{"key":"1301_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymgme.2013.02.004","volume":"109","author":"S Liu","year":"2013","unstructured":"Liu, S. et al. Do mitochondria contribute to left ventricular non-compaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy. Mol. Genet. Metab. 109, 100\u2013106 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/hrt.80.6.548","volume":"80","author":"E Arbustini","year":"1998","unstructured":"Arbustini, E. et al. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart 80, 548\u2013558 (1998).","journal-title":"Heart"},{"key":"1301_CR10","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1001\/jama.1991.03470130092035","volume":"266","author":"M Corral-Debrinski","year":"1991","unstructured":"Corral-Debrinski, M. et al. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA 266, 1812\u20131816 (1991).","journal-title":"JAMA"},{"key":"1301_CR11","doi-asserted-by":"crossref","first-page":"E2501","DOI":"10.1073\/pnas.1321776111","volume":"111","author":"W De Haes","year":"2014","unstructured":"De Haes, W. et al. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc. Natl Acad. Sci. USA 111, E2501\u2013E2509 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1301_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2203\/dose-response.13-035.Ristow","volume":"12","author":"M Ristow","year":"2014","unstructured":"Ristow, M. & Schmeisser, K. Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response 12, 288\u2013341 (2014).","journal-title":"Dose Response"},{"key":"1301_CR13","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/eurheartj\/ehad177","volume":"44","author":"E Braunwald","year":"2023","unstructured":"Braunwald, E. Mitochondrial cardiomyopathy: a fertile field for research. Eur. Heart J. 44, 2361\u20132362 (2023).","journal-title":"Eur. Heart J."},{"key":"1301_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijcard.2021.06.042","volume":"341","author":"A Imai-Okazaki","year":"2021","unstructured":"Imai-Okazaki, A. et al. Long-term prognosis and genetic background of cardiomyopathy in 223 pediatric mitochondrial disease patients. Int. J. Cardiol. 341, 48\u201355 (2021).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR15","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41588-018-0264-z","volume":"50","author":"DC Wallace","year":"2018","unstructured":"Wallace, D. C. Mitochondrial genetic medicine. Nat. Genet. 50, 1642\u20131649 (2018).","journal-title":"Nat. Genet."},{"key":"1301_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1621096","volume":"12","author":"R Adorisio","year":"2025","unstructured":"Adorisio, R. et al. Mitochondrial cardiomyopathies: navigating through different clinical and management pictures between adult and paediatric forms. Front. Cardiovasc. Med. 12, 1621096 (2025).","journal-title":"Front. Cardiovasc. Med."},{"key":"1301_CR17","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","volume":"33","author":"MG Bates","year":"2012","unstructured":"Bates, M. G. et al. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur. Heart J. 33, 3023\u20133033 (2012).","journal-title":"Eur. Heart J."},{"key":"1301_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","volume":"24","author":"D Holmgren","year":"2003","unstructured":"Holmgren, D. et al. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur. Heart J. 24, 280\u2013288 (2003).","journal-title":"Eur. Heart J."},{"key":"1301_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10545-011-9440-3","volume":"35","author":"T Honzik","year":"2012","unstructured":"Honzik, T. et al. Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis. J. Inherit. Metab. Dis. 35, 749\u2013759 (2012).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2019.01.017","volume":"279","author":"A Imai-Okazaki","year":"2019","unstructured":"Imai-Okazaki, A. et al. Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background. Int. J. Cardiol. 279, 115\u2013121 (2019).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jacc.2022.08.716","volume":"80","author":"K Savvatis","year":"2022","unstructured":"Savvatis, K. et al. Cardiac outcomes in adults with mitochondrial diseases. JACC 80, 1421\u20131430 (2022).","journal-title":"JACC"},{"key":"1301_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","volume":"263","author":"YS Ng","year":"2016","unstructured":"Ng, Y. S. & Turnbull, D. M. Mitochondrial disease: genetics and management. J. Neurol. 263, 179\u2013191 (2016).","journal-title":"J. Neurol."},{"key":"1301_CR23","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/acn3.52062","volume":"11","author":"C Rouzier","year":"2024","unstructured":"Rouzier, C. et al. Primary mitochondrial disorders and mimics: insights from a large French cohort. Ann. Clin. Transl. Neurol. 11, 1478\u20131491 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1301_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265744","volume":"17","author":"E Buajitti","year":"2022","unstructured":"Buajitti, E., Rosella, L. C., Zabzuni, E., Young, L. T. & Andreazza, A. C. Prevalence and health care costs of mitochondrial disease in Ontario, Canada: a population-based cohort study. PLoS One 17, e0265744 (2022).","journal-title":"PLoS One"},{"key":"1301_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2188\/jea.JE20200577","volume":"33","author":"K Ibayashi","year":"2023","unstructured":"Ibayashi, K. et al. Estimation of the number of patients with mitochondrial diseases: a descriptive study using a nationwide database in Japan. J. Epidemiol. 33, 68\u201375 (2023).","journal-title":"J. Epidemiol."},{"key":"1301_CR26","doi-asserted-by":"publisher","first-page":"951185","DOI":"10.3389\/fgene.2022.951185","volume":"13","author":"D Li","year":"2022","unstructured":"Li, D. et al. Pathogenic mitochondrial DNA 3243A>G mutation: from genetics to phenotype. Front. Genet. 13, 951185 (2022).","journal-title":"Front. Genet."},{"key":"1301_CR27","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/eurheartj\/ehv306","volume":"37","author":"YS Ng","year":"2016","unstructured":"Ng, Y. S. et al. Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults. Eur. Heart J. 37, 2552\u20132559 (2016).","journal-title":"Eur. Heart J."},{"key":"1301_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/ehjci\/jes226","volume":"14","author":"MG Bates","year":"2013","unstructured":"Bates, M. G. et al. Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers. Eur. Heart J. Cardiovasc. Imaging 14, 650\u2013658 (2013).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1301_CR29","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri, S. et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation 144, 1714\u20131731 (2021).","journal-title":"Circulation"},{"key":"1301_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.624216","volume":"8","author":"D Ramaccini","year":"2020","unstructured":"Ramaccini, D. et al. Mitochondrial function and dysfunction in dilated cardiomyopathy. Front. Cell Dev. Biol. 8, 624216 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1301_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajmg.c.31372","volume":"163","author":"JL Jefferies","year":"2013","unstructured":"Jefferies, J. L. Barth syndrome. Am. J. Med. Genet. Part C Semin. Med. Genet. 163, 198\u2013205 (2013).","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"1301_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/adc.2009.168096","volume":"95","author":"T Honz\u00edk","year":"2010","unstructured":"Honz\u00edk, T. et al. Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation. Arch. Dis. Child. 95, 296\u2013301 (2010).","journal-title":"Arch. Dis. Child."},{"key":"1301_CR33","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/01.CIR.0000100664.10777.B8","volume":"108","author":"RH Pignatelli","year":"2003","unstructured":"Pignatelli, R. H. et al. Clinical characterization of left ventricular noncompaction in children. Circulation 108, 2672\u20132678 (2003).","journal-title":"Circulation"},{"key":"1301_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2020.12.013","volume":"328","author":"K Hirono","year":"2021","unstructured":"Hirono, K. et al. A burden of sarcomere gene variants in fetal-onset patients with left ventricular noncompaction. Int. J. Cardiol. 328, 122\u2013129 (2021).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR35","doi-asserted-by":"publisher","first-page":"841523","DOI":"10.3389\/fcell.2022.841523","volume":"10","author":"J Yang","year":"2022","unstructured":"Yang, J., Guo, Q., Feng, X., Liu, Y. & Zhou, Y. Mitochondrial dysfunction in cardiovascular diseases: potential targets for treatment. Front. Cell Dev. Biol. 10, 841523 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1301_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymgme.2010.02.021","volume":"100","author":"B Chang","year":"2010","unstructured":"Chang, B. et al. Gonadal mosaicism of a TAZ (G4.5) mutation in a Japanese family with Barth syndrome and left ventricular noncompaction. Mol. Genet. Metab. 100, 198\u2013203 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"1301_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.111.000455","volume":"1","author":"CK Phoon","year":"2012","unstructured":"Phoon, C. K. et al. Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. J. Am. Heart Assoc. 1, jah3-e000455 (2012).","journal-title":"J. Am. Heart Assoc."},{"key":"1301_CR38","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymgme.2012.09.013","volume":"107","author":"D Ronvelia","year":"2012","unstructured":"Ronvelia, D., Greenwood, J., Platt, J., Hakim, S. & Zaragoza, M. V. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle. Mol. Genet. Metab. 107, 428\u2013432 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"1301_CR39","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ng.246","volume":"40","author":"A C\u00edzkov\u00e1","year":"2008","unstructured":"C\u00edzkov\u00e1, A. et al. TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy. Nat. Genet. 40, 1288\u20131290 (2008).","journal-title":"Nat. Genet."},{"key":"1301_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpeds.2017.09.075","volume":"193","author":"A Imai-Okazaki","year":"2018","unstructured":"Imai-Okazaki, A. et al. Barth syndrome: different approaches to diagnosis. J. Pediatr. 193, 256\u2013260 (2018).","journal-title":"J. Pediatr."},{"key":"1301_CR41","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","volume":"91","author":"R Anan","year":"1995","unstructured":"Anan, R. et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 91, 955\u2013961 (1995).","journal-title":"Circulation"},{"key":"1301_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70253","author":"FdJ Salazar-Ram\u00edrez","year":"2025","unstructured":"Salazar-Ram\u00edrez, F.dJ. et al. Mitochondrial Ca2+ overload is a pivotal risk factor for lethal ventricular arrhythmias due to the oxidation of mitochondrial respirasome and energetic failure. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.70253 (2025).","journal-title":"Br. J. Pharmacol."},{"key":"1301_CR43","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo, E. et al. 2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur. Heart J. 44, 3503\u20133626 (2023).","journal-title":"Eur. Heart J."},{"key":"1301_CR44","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","volume":"140","author":"SE Lipshultz","year":"2019","unstructured":"Lipshultz, S. E. et al. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circulation 140, e9\u2013e68 (2019).","journal-title":"Circulation"},{"key":"1301_CR45","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1253\/circj.CJ-20-0910","volume":"85","author":"H Kitaoka","year":"2021","unstructured":"Kitaoka, H. et al. JCS\/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies. Circ. J. 85, 1590\u20131689 (2021).","journal-title":"Circ. J."},{"key":"1301_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijcard.2022.03.050","volume":"357","author":"G Limongelli","year":"2022","unstructured":"Limongelli, G. et al. Diagnosis and management of rare cardiomyopathies in adult and paediatric patients. A position paper of the Italian Society of cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP). Int. J. Cardiol. 357, 55\u201371 (2022).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR47","first-page":"CD004426","volume":"2012","author":"G Pfeffer","year":"2012","unstructured":"Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D. & Chinnery, P. F. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. 2012, CD004426 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1301_CR48","doi-asserted-by":"publisher","first-page":"i40","DOI":"10.1093\/eurheartjsupp\/suae099","volume":"27","author":"F Angelini","year":"2025","unstructured":"Angelini, F. et al. From thick walls to clear answers: approaches to diagnosing hypertrophic cardiomyopathy and its mimics. Eur. Heart J. Suppl. 27, i40\u2013i46 (2025).","journal-title":"Eur. Heart J. Suppl."},{"key":"1301_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12968-016-0245-2","volume":"18","author":"Y Choi","year":"2016","unstructured":"Choi, Y. et al. Quantification of left ventricular trabeculae using cardiovascular magnetic resonance for the diagnosis of left ventricular non-compaction: evaluation of trabecular volume and refined semi-quantitative criteria. J. Cardiovasc. Magn. Reson. 18, 24 (2016).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1301_CR50","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jacc.2016.05.096","volume":"68","author":"E Arbustini","year":"2016","unstructured":"Arbustini, E., Favalli, V., Narula, N., Serio, A. & Grasso, M. Left ventricular noncompaction. JACC 68, 949\u2013966 (2016).","journal-title":"JACC"},{"key":"1301_CR51","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s12350-010-9223-5","volume":"17","author":"MH Al-Mallah","year":"2010","unstructured":"Al-Mallah, M. H., Sitek, A., Moore, S. C., Di Carli, M. & Dorbala, S. Assessment of myocardial perfusion and function with PET and PET\/CT. J. Nucl. Cardiol. 17, 498\u2013513 (2010).","journal-title":"J. Nucl. Cardiol."},{"key":"1301_CR52","doi-asserted-by":"publisher","first-page":"e1592","DOI":"10.1212\/WNL.0000000000009249","volume":"94","author":"T Terada","year":"2020","unstructured":"Terada, T. et al. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease. Neurology 94, e1592\u2013e1604 (2020).","journal-title":"Neurology"},{"key":"1301_CR53","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/156652409789839099","volume":"9","author":"M Mancuso","year":"2009","unstructured":"Mancuso, M. et al. Diagnostic approach to mitochondrial disorders: the need for a reliable biomarker. Curr. Mol. Med. 9, 1095\u20131107 (2009).","journal-title":"Curr. Mol. Med."},{"key":"1301_CR54","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1373\/clinchem.2006.081166","volume":"53","author":"FG Debray","year":"2007","unstructured":"Debray, F. G. et al. Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. Clin. Chem. 53, 916\u2013921 (2007).","journal-title":"Clin. Chem."},{"key":"1301_CR55","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/acn3.51104","volume":"7","author":"Y Lin","year":"2020","unstructured":"Lin, Y. et al. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: a meta-analysis. Ann. Clin. Transl. Neurol. 7, 1204\u20131213 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1301_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.851534","volume":"10","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Circulating FGF21 and GDF15 as biomarkers for screening, diagnosis, and severity assessment of primary mitochondrial disorders in children. Front. Pediatr. 10, 851534 (2022).","journal-title":"Front. Pediatr."},{"key":"1301_CR57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jimd.12307","volume":"44","author":"JM Lehtonen","year":"2021","unstructured":"Lehtonen, J. M. et al. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease. J. Inherit. Metab. Dis. 44, 469\u2013480 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/metabo9120306","volume":"9","author":"EM Fatica","year":"2019","unstructured":"Fatica, E. M. et al. Barth syndrome: exploring cardiac metabolism with induced pluripotent stem cell-derived cardiomyocytes. Metabolites 9, 306 (2019).","journal-title":"Metabolites"},{"key":"1301_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1194\/jlr.R012120","volume":"53","author":"HK Saini-Chohan","year":"2012","unstructured":"Saini-Chohan, H. K., Mitchell, R. W., Vaz, F. M., Zelinski, T. & Hatch, G. M. Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: thematic review series: genetics of human lipid diseases. J. Lipid Res. 53, 4\u201327 (2012).","journal-title":"J. Lipid Res."},{"key":"1301_CR60","doi-asserted-by":"publisher","first-page":"e2318","DOI":"10.1212\/WNL.0000000000200299","volume":"98","author":"RJ Stefanetti","year":"2022","unstructured":"Stefanetti, R. J. et al. L-arginine in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes: a systematic review. Neurology 98, e2318\u2013e2328 (2022).","journal-title":"Neurology"},{"key":"1301_CR61","volume":"14","author":"JM Argudo","year":"2022","unstructured":"Argudo, J. M. et al. Arginine for the treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes: a systematic review. Cureus 14, e32709 (2022).","journal-title":"Cureus"},{"key":"1301_CR62","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga, S. et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann. Neurol. 78, 814\u2013823 (2015).","journal-title":"Ann. Neurol."},{"key":"1301_CR63","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1542\/peds.2004-0718","volume":"114","author":"F Scaglia","year":"2004","unstructured":"Scaglia, F. et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 114, 925\u2013931 (2004).","journal-title":"Pediatrics"},{"key":"1301_CR64","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mito.2017.07.004","volume":"36","author":"L Caporali","year":"2017","unstructured":"Caporali, L. et al. Incomplete penetrance in mitochondrial optic neuropathies. Mitochondrion 36, 130\u2013137 (2017).","journal-title":"Mitochondrion"},{"key":"1301_CR65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","volume":"137","author":"C Giordano","year":"2014","unstructured":"Giordano, C. et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy. Brain 137, 335\u2013353 (2014).","journal-title":"Brain"},{"key":"1301_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2261-2-12","volume":"2","author":"K Majamaa-Voltti","year":"2002","unstructured":"Majamaa-Voltti, K., Peuhkurinen, K., Kortelainen, M. L., Hassinen, I. E. & Majamaa, K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc. Disord. 2, 12 (2002).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1301_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2337\/db24-0515","volume":"74","author":"JP Chanoine","year":"2025","unstructured":"Chanoine, J. P., Thompson, D. M. & Lehman, A. Diabetes associated with maternally inherited diabetes and deafness (MIDD): from pathogenic variant to phenotype. Diabetes 74, 153\u2013163 (2025).","journal-title":"Diabetes"},{"key":"1301_CR68","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jdiacomp.2014.03.006","volume":"28","author":"A Naing","year":"2014","unstructured":"Naing, A. et al. Maternally inherited diabetes and deafness (MIDD): diagnosis and management. J. Diabetes Complications 28, 542\u2013546 (2014).","journal-title":"J. Diabetes Complications"},{"key":"1301_CR69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijcard.2016.01.026","volume":"207","author":"A Imai","year":"2016","unstructured":"Imai, A. et al. Rapidly progressive infantile cardiomyopathy with mitochondrial respiratory chain complex V deficiency due to loss of ATPase 6 and 8 protein. Int. J. Cardiol. 207, 203\u2013205 (2016).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR70","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/WNL.0b013e3181d0ccf4","volume":"74","author":"K Wahbi","year":"2010","unstructured":"Wahbi, K. et al. Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA. Neurology 74, 674\u2013677 (2010).","journal-title":"Neurology"},{"key":"1301_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","volume":"181","author":"P Kabunga","year":"2015","unstructured":"Kabunga, P. et al. Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy. Int. J. Cardiol. 181, 303\u2013310 (2015).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR72","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ijcard.2014.11.014","volume":"177","author":"J Finsterer","year":"2014","unstructured":"Finsterer, J. & Kothari, S. Cardiac manifestations of primary mitochondrial disorders. Int. J. Cardiol. 177, 754\u2013763 (2014).","journal-title":"Int. J. Cardiol."},{"key":"1301_CR73","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1056\/NEJMoa2001265","volume":"383","author":"MA Walker","year":"2020","unstructured":"Walker, M. A. et al. Purifying selection against pathogenic mitochondrial DNA in human T cells. N. Engl. J. Med. 383, 1556\u20131563 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1301_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1509","volume":"8","author":"V Sabella-Jim\u00e9nez","year":"2020","unstructured":"Sabella-Jim\u00e9nez, V., Otero-Herrera, C., Silvera-Redondo, C. & Garavito-Galofre, P. Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome (KSS) with initial presentation as pearson marrow-pancreas syndrome (PMPS): Two case reports in Barranquilla, Colombia. Mol. Genet. Genomic Med. 8, e1509 (2020).","journal-title":"Mol. Genet. Genomic Med."},{"key":"1301_CR75","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1203\/00006450-199206000-00004","volume":"31","author":"N Fischel-Ghodsian","year":"1992","unstructured":"Fischel-Ghodsian, N. et al. Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome. Pediatr. Res. 31, 557\u2013560 (1992).","journal-title":"Pediatr. Res."},{"key":"1301_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2016.00025","volume":"3","author":"AW El-Hattab","year":"2016","unstructured":"El-Hattab, A. W. & Scaglia, F. Mitochondrial cardiomyopathies. Front. Cardiovasc. Med. 3, 25 (2016).","journal-title":"Front. Cardiovasc. Med."},{"key":"1301_CR77","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1093\/hmg\/ddae059","volume":"33","author":"SP Burr","year":"2024","unstructured":"Burr, S. P. & Chinnery, P. F. Origins of tissue and cell-type specificity in mitochondrial DNA (mtDNA) disease. Hum. Mol. Genet. 33, R3\u2013R11 (2024).","journal-title":"Hum. Mol. Genet."},{"key":"1301_CR78","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/jimd.12547","volume":"45","author":"A Imai-Okazaki","year":"2022","unstructured":"Imai-Okazaki, A. et al. Impact of measuring heteroplasmy of a pathogenic mitochondrial DNA variant at the single-cell level in individuals with mitochondrial disease. J. Inherit. Metab. Dis. 45, 1143\u20131150 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78270-0","volume":"14","author":"B Slapnik","year":"2024","unstructured":"Slapnik, B. et al. The quality and detection limits of mitochondrial heteroplasmy by long read nanopore sequencing. Sci. Rep. 14, 26778 (2024).","journal-title":"Sci. Rep."},{"key":"1301_CR80","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-024-07332-0","volume":"629","author":"AV Kotrys","year":"2024","unstructured":"Kotrys, A. V. et al. Single-cell analysis reveals context-dependent, cell-level selection of mtDNA. Nature 629, 458\u2013466 (2024).","journal-title":"Nature"},{"key":"1301_CR81","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41587-020-0645-6","volume":"39","author":"CA Lareau","year":"2021","unstructured":"Lareau, C. A. et al. Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling. Nat. Biotechnol. 39, 451\u2013461 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1301_CR82","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41587-021-00927-2","volume":"39","author":"EP Mimitou","year":"2021","unstructured":"Mimitou, E. P. et al. Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells. Nat. Biotechnol. 39, 1246\u20131258 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1301_CR83","doi-asserted-by":"publisher","first-page":"12278","DOI":"10.1096\/fj.202000959RR","volume":"34","author":"HS Rosa","year":"2020","unstructured":"Rosa, H. S., Ajaz, S., Gnudi, L. & Malik, A. N. A case for measuring both cellular and cell-free mitochondrial DNA as a disease biomarker in human blood. FASEB J. 34, 12278\u201312288 (2020).","journal-title":"FASEB J."},{"key":"1301_CR84","doi-asserted-by":"publisher","first-page":"201198","DOI":"10.1016\/j.humgen.2023.201198","volume":"37","author":"A Chattopadhyay","year":"2023","unstructured":"Chattopadhyay, A., Tak, H. & Hemanth Naick, B. Cell-free mitochondrial DNA as a novel biomarker for stress-related conditions \u2014 meta-analysis. Hum. Gene 37, 201198 (2023).","journal-title":"Hum. Gene"},{"key":"1301_CR85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mito.2021.04.002","volume":"59","author":"C Trumpff","year":"2021","unstructured":"Trumpff, C. et al. Stress and circulating cell-free mitochondrial DNA: a systematic review of human studies, physiological considerations, and technical recommendations. Mitochondrion 59, 225\u2013245 (2021).","journal-title":"Mitochondrion"},{"key":"1301_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","volume":"10","author":"H Wen","year":"2025","unstructured":"Wen, H. et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct. Target. Ther. 10, 9 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1301_CR87","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","volume":"20","author":"YS Ng","year":"2021","unstructured":"Ng, Y. S. et al. Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol. 20, 573\u2013584 (2021).","journal-title":"Lancet Neurol."},{"key":"1301_CR88","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/acn3.532","volume":"5","author":"SJ Pickett","year":"2018","unstructured":"Pickett, S. J. et al. Phenotypic heterogeneity in m.3243A>G mitochondrial disease: the role of nuclear factors. Ann. Clin. Transl. Neurol. 5, 333\u2013345 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1301_CR89","doi-asserted-by":"publisher","first-page":"600079","DOI":"10.3389\/fcell.2020.600079","volume":"8","author":"LD Schlieben","year":"2020","unstructured":"Schlieben, L. D. & Prokisch, H. The dimensions of primary mitochondrial disorders. Front. Cell Dev. Biol. 8, 600079 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1301_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s13311-013-0185-6","volume":"10","author":"AC Goldstein","year":"2013","unstructured":"Goldstein, A. C., Bhatia, P. & Vento, J. M. Mitochondrial disease in childhood: nuclear encoded. Neurotherapeutics 10, 212\u2013226 (2013).","journal-title":"Neurotherapeutics"},{"key":"1301_CR91","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath, S. et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 49, D1541\u2013D1547 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1301_CR92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157504","volume":"132","author":"MK Shammas","year":"2022","unstructured":"Shammas, M. K. et al. OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy. J. Clin. Invest. 132, e157504 (2022).","journal-title":"J. Clin. Invest."},{"key":"1301_CR93","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.medj.2020.06.004","volume":"2","author":"AE Frazier","year":"2021","unstructured":"Frazier, A. E. et al. Fatal perinatal mitochondrial cardiac failure caused by recurrent de novo duplications in the ATAD3 locus. Med 2, 49\u201373 (2021).","journal-title":"Med"},{"key":"1301_CR94","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ejhg.2010.204","volume":"19","author":"SJ Hoefs","year":"2011","unstructured":"Hoefs, S. J. et al. NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease. Eur. J. Hum. Genet. 19, 270\u2013274 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"1301_CR95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/jmedgenet-2011-100577","volume":"49","author":"TB Haack","year":"2012","unstructured":"Haack, T. B. et al. Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9. J. Med. Genet. 49, 83\u201389 (2012).","journal-title":"J. Med. Genet."},{"key":"1301_CR96","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.706","volume":"42","author":"TB Haack","year":"2010","unstructured":"Haack, T. B. et al. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat. Genet. 42, 1131\u20131134 (2010).","journal-title":"Nat. Genet."},{"key":"1301_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0784-8","volume":"13","author":"BM Repp","year":"2018","unstructured":"Repp, B. M. et al. Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective? Orphanet J. Rare Dis. 13, 120 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"1301_CR98","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ejhg.2011.18","volume":"19","author":"H Swalwell","year":"2011","unstructured":"Swalwell, H. et al. Respiratory chain complex I deficiency caused by mitochondrial DNA mutations. Eur. J. Hum. Genet. 19, 769\u2013775 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"1301_CR99","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510X(83)90209-5","volume":"62","author":"PG Barth","year":"1983","unstructured":"Barth, P. G. et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62, 327\u2013355 (1983).","journal-title":"J. Neurol. Sci."},{"key":"1301_CR100","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/CIRCRESAHA.117.310987","volume":"121","author":"JA Towbin","year":"2017","unstructured":"Towbin, J. A. & Jefferies, J. L. Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circ. Res. 121, 838\u2013854 (2017).","journal-title":"Circ. Res."},{"key":"1301_CR101","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ymgme.2014.03.007","volume":"112","author":"HJ Vernon","year":"2014","unstructured":"Vernon, H. J., Sandlers, Y., McClellan, R. & Kelley, R. I. Clinical laboratory studies in Barth syndrome. Mol. Genet. Metab. 112, 143\u2013147 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"1301_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005679","volume":"12","author":"M Kohda","year":"2016","unstructured":"Kohda, M. et al. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 12, e1005679 (2016).","journal-title":"PLoS Genet."},{"key":"1301_CR103","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10545-012-9489-7","volume":"36","author":"TB Haack","year":"2013","unstructured":"Haack, T. B. et al. Homozygous missense mutation in BOLA3 causes multiple mitochondrial dysfunctions syndrome in two siblings. J. Inherit. Metab. Dis. 36, 55\u201362 (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR104","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/jhg.2016.85","volume":"61","author":"A Imai","year":"2016","unstructured":"Imai, A. et al. HDR: a statistical two-step approach successfully identifies disease genes in autosomal recessive families. J. Hum. Genet. 61, 959\u2013963 (2016).","journal-title":"J. Hum. Genet."},{"key":"1301_CR105","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.0906784106","volume":"106","author":"ML Huang","year":"2009","unstructured":"Huang, M. L. et al. Elucidation of the mechanism of mitochondrial iron loading in Friedreich\u2019s ataxia by analysis of a mouse mutant. Proc. Natl Acad. Sci. USA 106, 16381\u201316386 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1301_CR106","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.cell.2019.03.045","volume":"177","author":"T Ast","year":"2019","unstructured":"Ast, T. et al. Hypoxia rescues frataxin loss by restoring iron sulfur cluster biogenesis. Cell 177, 1507\u20131521.e16 (2019).","journal-title":"Cell"},{"key":"1301_CR107","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ymgme.2016.05.005","volume":"118","author":"JP Dewulf","year":"2016","unstructured":"Dewulf, J. P. et al. Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: report on nine patients. Mol. Genet. Metab. 118, 185\u2013189 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"1301_CR108","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/humu.22393","volume":"34","author":"E Baruffini","year":"2013","unstructured":"Baruffini, E. et al. MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum. Mutat. 34, 1501\u20131509 (2013).","journal-title":"Hum. Mutat."},{"key":"1301_CR109","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ajhg.2011.04.006","volume":"88","author":"A G\u00f6tz","year":"2011","unstructured":"G\u00f6tz, A. et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am. J. Hum. Genet. 88, 635\u2013642 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"1301_CR110","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ejhg.2014.35","volume":"22","author":"V Nesbitt","year":"2014","unstructured":"Nesbitt, V. et al. A national perspective on prenatal testing for mitochondrial disease. Eur. J. Hum. Genet. 22, 1255\u20131259 (2014).","journal-title":"Eur. J. Hum. Genet."},{"key":"1301_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmg.2010.06.018","volume":"4","author":"N Narula","year":"2011","unstructured":"Narula, N. et al. Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis. JACC Cardiovasc. Imaging 4, 1\u201310 (2011).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"1301_CR112","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1101\/gad.1784909","volume":"23","author":"DC Wallace","year":"2009","unstructured":"Wallace, D. C. & Fan, W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 23, 1714\u20131736 (2009).","journal-title":"Genes Dev."},{"key":"1301_CR113","doi-asserted-by":"publisher","first-page":"14592","DOI":"10.1016\/S0021-9258(18)42082-0","volume":"267","author":"G Stepien","year":"1992","unstructured":"Stepien, G., Torroni, A., Chung, A. B., Hodge, J. A. & Wallace, D. C. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol. Chem. 267, 14592\u201314597 (1992).","journal-title":"J. Biol. Chem."},{"key":"1301_CR114","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.bbabio.2016.03.026","volume":"1857","author":"JE Kokoszka","year":"2016","unstructured":"Kokoszka, J. E. et al. Deficiency in the mouse mitochondrial adenine nucleotide translocator isoform 2 gene is associated with cardiac noncompaction. Biochim. Biophys. Acta 1857, 1203\u20131212 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"1301_CR115","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ajhg.2016.08.014","volume":"99","author":"K Thompson","year":"2016","unstructured":"Thompson, K. et al. Recurrent de novo dominant mutations in SLC25A4 cause severe early-onset mitochondrial disease and loss of mitochondrial DNA copy number. Am. J. Hum. Genet. 99, 860\u2013876 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"1301_CR116","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/hmg\/ddr200","volume":"20","author":"H Kawamata","year":"2011","unstructured":"Kawamata, H., Tiranti, V., Magran\u00e9, J., Chinopoulos, C. & Manfredi, G. adPEO mutations in ANT1 impair ADP-ATP translocation in muscle mitochondria. Hum. Mol. Genet. 20, 2964\u20132974 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1301_CR117","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1212\/WNL.57.12.2295","volume":"57","author":"L Napoli","year":"2001","unstructured":"Napoli, L. et al. A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. Neurology 57, 2295\u20132298 (2001).","journal-title":"Neurology"},{"key":"1301_CR118","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1073\/pnas.1700997114","volume":"114","author":"RM Morrow","year":"2017","unstructured":"Morrow, R. M. et al. Mitochondrial energy deficiency leads to hyperproliferation of skeletal muscle mitochondria and enhanced insulin sensitivity. Proc. Natl Acad. Sci. USA 114, 2705\u20132710 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1301_CR119","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1073\/pnas.96.9.4820","volume":"96","author":"LA Esposito","year":"1999","unstructured":"Esposito, L. A., Melov, S., Panov, A., Cottrell, B. A. & Wallace, D. C. Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl Acad. Sci. USA 96, 4820\u20134825 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1301_CR120","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/humu.24107","volume":"41","author":"EM McCormick","year":"2020","unstructured":"McCormick, E. M. et al. Specifications of the ACMG\/AMP standards and guidelines for mitochondrial DNA variant interpretation. Hum. Mutat. 41, 2028\u20132057 (2020).","journal-title":"Hum. Mutat."},{"key":"1301_CR121","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-12-821751-1.00011-7","volume":"194","author":"LD Schlieben","year":"2023","unstructured":"Schlieben, L. D. & Prokisch, H. Genetics of mitochondrial diseases: current approaches for the molecular diagnosis. Handb. Clin. Neurol. 194, 141\u2013165 (2023).","journal-title":"Handb. Clin. Neurol."},{"key":"1301_CR122","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2018.08.002","volume":"29","author":"MJ McManus","year":"2019","unstructured":"McManus, M. J. et al. Mitochondrial DNA variation dictates expressivity and progression of nuclear DNA mutations causing cardiomyopathy. Cell Metab. 29, 78\u201390.e5 (2019).","journal-title":"Cell Metab."},{"key":"1301_CR123","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mito.2019.03.003","volume":"48","author":"P Govindaraj","year":"2019","unstructured":"Govindaraj, P. et al. Mitochondrial genome variations in idiopathic dilated cardiomyopathy. Mitochondrion 48, 51\u201359 (2019).","journal-title":"Mitochondrion"},{"key":"1301_CR124","doi-asserted-by":"publisher","first-page":"1496142","DOI":"10.3389\/fnins.2024.1496142","volume":"18","author":"M Br\u00fcgel","year":"2024","unstructured":"Br\u00fcgel, M., Kiesel, A. S., Haack, T. B. & Peralta, S. Mutations in mitochondrial ATAD3 gene and disease, lessons from in vivo models. Front. Neurosci. 18, 1496142 (2024).","journal-title":"Front. Neurosci."},{"key":"1301_CR125","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0022-3476(94)70308-6","volume":"124","author":"P Rustin","year":"1994","unstructured":"Rustin, P. et al. Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies. J. Pediatrics 124, 224\u2013228 (1994).","journal-title":"J. Pediatrics"},{"key":"1301_CR126","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/BF00711676","volume":"16","author":"P Rustin","year":"1993","unstructured":"Rustin, P. et al. The investigation of respiratory chain disorders in heart using endomyocardial biopsies. J. Inherit. Metab. Dis. 16, 541\u2013544 (1993).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR127","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/jimd.12218","volume":"43","author":"E Ogawa","year":"2020","unstructured":"Ogawa, E. et al. Mortality of Japanese patients with Leigh syndrome: effects of age at onset and genetic diagnosis. J. Inherit. Metab. Dis. 43, 819\u2013826 (2020).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR128","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/jmg-2022-109027","volume":"60","author":"Y Kishita","year":"2023","unstructured":"Kishita, Y. et al. Strategic validation of variants of uncertain significance in ECHS1 genetic testing. J. Med. Genet. 60, 1006\u20131015 (2023).","journal-title":"J. Med. Genet."},{"key":"1301_CR129","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh, S. et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet. Med. 17, 689\u2013701 (2015).","journal-title":"Genet. Med."},{"key":"1301_CR130","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jpeds.2019.10.016","volume":"217","author":"JG Weiner","year":"2020","unstructured":"Weiner, J. G. et al. Heart transplantation in children with mitochondrial disease. J. Pediatrics 217, 46\u201351.e4 (2020).","journal-title":"J. Pediatrics"},{"key":"1301_CR131","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001819","volume":"9","author":"JP Bourke","year":"2022","unstructured":"Bourke, J. P. et al. Arrhythmia prevalence and sudden death risk in adults with the m.3243A>G mitochondrial disorder. Open Heart 9, e001819 (2022).","journal-title":"Open Heart"},{"key":"1301_CR132","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/antiox10050755","volume":"10","author":"Y Rabanal-Ruiz","year":"2021","unstructured":"Rabanal-Ruiz, Y., Llanos-Gonz\u00e1lez, E. & Alcain, F. J. The use of coenzyme Q10 in cardiovascular diseases. Antioxidants 10, 755 (2021).","journal-title":"Antioxidants"},{"key":"1301_CR133","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/heart.87.4.346","volume":"87","author":"AO Hausse","year":"2002","unstructured":"Hausse, A. O. et al. Idebenone and reduced cardiac hypertrophy in Friedreich\u2019s ataxia. Heart 87, 346\u2013349 (2002).","journal-title":"Heart"},{"key":"1301_CR134","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","volume":"161","author":"SJ Lagedrost","year":"2011","unstructured":"Lagedrost, S. J. et al. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Am. Heart J. 161, 639\u2013645.e1 (2011).","journal-title":"Am. Heart J."},{"key":"1301_CR135","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","volume":"71","author":"MJ Rossman","year":"2018","unstructured":"Rossman, M. J. et al. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension 71, 1056\u20131063 (2018).","journal-title":"Hypertension"},{"key":"1301_CR136","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40360-021-00518-6","volume":"22","author":"B Sacks","year":"2021","unstructured":"Sacks, B. et al. Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment. BMC Pharmacol. Toxicol. 22, 49 (2021).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"1301_CR137","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2018.01.012","volume":"117","author":"RF Ribeiro Junior","year":"2018","unstructured":"Ribeiro Junior, R. F. et al. MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload. Free Radic. Biol. Med. 117, 18\u201329 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"1301_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.980783","volume":"13","author":"KO Murray","year":"2022","unstructured":"Murray, K. O. et al. Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans: a study protocol. Front. Physiol. 13, 980783 (2022).","journal-title":"Front. Physiol."},{"key":"1301_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1047909","volume":"13","author":"B Jia","year":"2022","unstructured":"Jia, B. et al. Mitochondrial antioxidant SkQ1 decreases inflammation following hemorrhagic shock by protecting myocardial mitochondria. Front. Physiol. 13, 1047909 (2022).","journal-title":"Front. Physiol."},{"key":"1301_CR140","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.bpj.2008.10.042","volume":"96","author":"K Chandran","year":"2009","unstructured":"Chandran, K. et al. Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys. J. 96, 1388\u20131398 (2009).","journal-title":"Biophys. J."},{"key":"1301_CR141","doi-asserted-by":"publisher","first-page":"H1422","DOI":"10.1152\/ajpheart.2001.281.3.H1422","volume":"281","author":"H Van Remmen","year":"2001","unstructured":"Van Remmen, H. et al. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am. J. Physiol. Heart Circ. Physiol. 281, H1422\u2013H1432 (2001).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1301_CR142","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jacc.2006.02.075","volume":"48","author":"VP van Empel","year":"2006","unstructured":"van Empel, V. P. et al. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J. Am. Coll. Cardiol. 48, 824\u2013832 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1301_CR143","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1161\/CIRCULATIONAHA.108.822403","volume":"119","author":"DF Dai","year":"2009","unstructured":"Dai, D. F. et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119, 2789\u20132797 (2009).","journal-title":"Circulation"},{"key":"1301_CR144","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1126\/science.1106653","volume":"308","author":"SE Schriner","year":"2005","unstructured":"Schriner, S. E. et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909\u20131911 (2005).","journal-title":"Science"},{"key":"1301_CR145","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","volume":"10","author":"MA Daubert","year":"2017","unstructured":"Daubert, M. A. et al. Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide. Circ. Heart Fail. 10, e004389 (2017).","journal-title":"Circ. Heart Fail."},{"key":"1301_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101138","volume":"26","author":"WR Thompson","year":"2024","unstructured":"Thompson, W. R. et al. Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER. Genet. Med. 26, 101138 (2024).","journal-title":"Genet. Med."},{"key":"1301_CR147","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2217\/fca-2023-0008","volume":"19","author":"HN Sabbah","year":"2023","unstructured":"Sabbah, H. N., Taylor, C. & Vernon, H. J. Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide. Future Cardiol. 19, 211\u2013225 (2023).","journal-title":"Future Cardiol."},{"key":"1301_CR148","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","volume":"583","author":"BY Mok","year":"2020","unstructured":"Mok, B. Y. et al. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature 583, 631\u2013637 (2020).","journal-title":"Nature"},{"key":"1301_CR149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cell.2023.11.035","volume":"187","author":"SI Cho","year":"2024","unstructured":"Cho, S. I. et al. Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA. Cell 187, 95\u2013109.e26 (2024).","journal-title":"Cell"},{"key":"1301_CR150","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s12276-023-00973-7","volume":"55","author":"HTL Phan","year":"2023","unstructured":"Phan, H. T. L., Lee, H. & Kim, K. Trends and prospects in mitochondrial genome editing. Exp. Mol. Med. 55, 871\u2013878 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1301_CR151","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41587-022-01486-w","volume":"41","author":"S Lee","year":"2023","unstructured":"Lee, S., Lee, H., Baek, G. & Kim, J.-S. Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors. Nat. Biotechnol. 41, 378\u2013386 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1301_CR152","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41587-022-01256-8","volume":"40","author":"BY Mok","year":"2022","unstructured":"Mok, B. Y. et al. CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA. Nat. Biotechnol. 40, 1378\u20131387 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1301_CR153","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41587-023-01791-y","volume":"42","author":"Z Yi","year":"2024","unstructured":"Yi, Z. et al. Strand-selective base editing of human mitochondrial DNA using mitoBEs. Nat. Biotechnol. 42, 498\u2013509 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1301_CR154","doi-asserted-by":"publisher","first-page":"952755","DOI":"10.3389\/fcvm.2022.952755","volume":"9","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Zhan, Q., Huang, B., Wang, Y. & Wang, X. AAV-mediated gene therapy: advancing cardiovascular disease treatment. Front. Cardiovasc. Med. 9, 952755 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1301_CR155","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jimd.12699","volume":"47","author":"N Keshavan","year":"2024","unstructured":"Keshavan, N., Minczuk, M., Viscomi, C. & Rahman, S. Gene therapy for mitochondrial disorders. J. Inherit. Metab. Dis. 47, 145\u2013175 (2024).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1301_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67134-4","volume":"17","author":"A Angelin","year":"2025","unstructured":"Angelin, A. et al. Partial restoration of mitochondrial dysfunction by AAV-Ant1 protects from dilated cardiomyopathy in Ant1-\/- plus mtDNA mutant mice. Nat. Commun. 17, 447 (2025).","journal-title":"Nat. Commun."},{"key":"1301_CR157","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","volume":"126","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. AAV gene therapy prevents and reverses heart failure in a murine knockout model of Barth syndrome. Circ. Res. 126, 1024\u20131039 (2020).","journal-title":"Circ. Res."},{"key":"1301_CR158","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-022-00715-9","volume":"18","author":"M Falabella","year":"2022","unstructured":"Falabella, M., Minczuk, M., Hanna, M. G., Viscomi, C. & Pitceathly, R. D. S. Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges. Nat. Rev. Neurol. 18, 689\u2013698 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"1301_CR159","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/nar\/gkq769","volume":"39","author":"E Perales-Clemente","year":"2011","unstructured":"Perales-Clemente, E., Fernandez-Silva, P., Acin-Perez, R., Perez-Martos, A. & Enriquez, J. A. Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task? Nucleic Acids Res. 39, 225\u2013234 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1301_CR160","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJM198905183202002","volume":"320","author":"G Singh","year":"1989","unstructured":"Singh, G., Lott, M. T. & Wallace, D. C. A mitochondrial DNA mutation as a cause of Leber\u2019s hereditary optic neuropathy. N. Engl. J. Med. 320, 1300\u20131305 (1989).","journal-title":"N. Engl. J. Med."},{"key":"1301_CR161","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1001\/jamaophthalmol.2024.5375","volume":"143","author":"P Yu-Wai-Man","year":"2025","unstructured":"Yu-Wai-Man, P. et al. Five-year outcomes of lenadogene nolparvovec gene therapy in Leber hereditary optic neuropathy. JAMA Ophthalmol. 143, 99\u2013108 (2025).","journal-title":"JAMA Ophthalmol."},{"key":"1301_CR162","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nature18303","volume":"534","author":"LA Hyslop","year":"2016","unstructured":"Hyslop, L. A. et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease. Nature 534, 383\u2013386 (2016).","journal-title":"Nature"},{"key":"1301_CR163","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/cr.2017.48","volume":"27","author":"K Wu","year":"2017","unstructured":"Wu, K. et al. Mitochondrial replacement by pre-pronuclear transfer in human embryos. Cell Res. 27, 834\u2013837 (2017).","journal-title":"Cell Res."},{"key":"1301_CR164","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.rbmo.2017.01.013","volume":"34","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod. Biomed. Online 34, 361\u2013368 (2017).","journal-title":"Reprod. Biomed. Online"},{"key":"1301_CR165","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature20592","volume":"540","author":"E Kang","year":"2016","unstructured":"Kang, E. et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature 540, 270\u2013275 (2016).","journal-title":"Nature"},{"key":"1301_CR166","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJMoa2503658","volume":"393","author":"R McFarland","year":"2025","unstructured":"McFarland, R. et al. Mitochondrial donation in a reproductive care pathway for mtDNA disease. N. Engl. J. Med. 393, 461\u2013468 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1301_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17813-0","volume":"7","author":"DB Cowan","year":"2017","unstructured":"Cowan, D. B. et al. Transit and integration of extracellular mitochondria in human heart cells. Sci. Rep. 7, 17450 (2017).","journal-title":"Sci. Rep."},{"key":"1301_CR168","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014501","volume":"9","author":"P Ali Pour","year":"2020","unstructured":"Ali Pour, P., Kenney, M. C. & Kheradvar, A. Bioenergetics consequences of mitochondrial transplantation in cardiomyocytes. J. Am. Heart Assoc. 9, e014501 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"1301_CR169","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/stem.632","volume":"29","author":"A Acquistapace","year":"2011","unstructured":"Acquistapace, A. et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cell 29, 812\u2013824 (2011).","journal-title":"Stem Cell"},{"key":"1301_CR170","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown, D. A. et al. Mitochondrial function as a therapeutic target in heart failure. Nat. Rev. Cardiol. 14, 238\u2013250 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"1301_CR171","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.apsb.2022.10.008","volume":"13","author":"TG Zhang","year":"2023","unstructured":"Zhang, T. G. & Miao, C. Y. Mitochondrial transplantation as a promising therapy for mitochondrial diseases. Acta Pharm. Sin. B 13, 1028\u20131035 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"1301_CR172","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nm.3545","volume":"20","author":"G Wang","year":"2014","unstructured":"Wang, G. et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616\u2013623 (2014).","journal-title":"Nat. Med."},{"key":"1301_CR173","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jacc.2020.12.060","volume":"77","author":"G Ikeda","year":"2021","unstructured":"Ikeda, G. et al. Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. JACC 77, 1073\u20131088 (2021).","journal-title":"JACC"},{"key":"1301_CR174","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2019.09.002","volume":"26","author":"V Weissig","year":"2020","unstructured":"Weissig, V. Drug development for the therapy of mitochondrial diseases. Trends Mol. Med. 26, 40\u201357 (2020).","journal-title":"Trends Mol. Med."},{"key":"1301_CR175","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41569-018-0074-0","volume":"16","author":"M Bonora","year":"2019","unstructured":"Bonora, M. et al. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nat. Rev. Cardiol. 16, 33\u201355 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"1301_CR176","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/CIRCRESAHA.112.265660","volume":"111","author":"AM Walters","year":"2012","unstructured":"Walters, A. M., Porter, G. A. & Brookes, P. S. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ. Res. 111, 1222\u20131236 (2012).","journal-title":"Circ. Res."},{"key":"1301_CR177","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cpt.1286","volume":"105","author":"B Nugraha","year":"2019","unstructured":"Nugraha, B., Buono, M. F., von Boehmer, L., Hoerstrup, S. P. & Emmert, M. Y. Human cardiac organoids for disease modeling. Clin. Pharmacol. Ther. 105, 79\u201385 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1301_CR178","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-017-0181-2","volume":"7","author":"RR Ramsay","year":"2018","unstructured":"Ramsay, R. R., Popovic-Nikolic, M. R., Nikolic, K., Uliassi, E. & Bolognesi, M. L. A perspective on multi-target drug discovery and design for complex diseases. Clin. Transl. Med. 7, 3 (2018).","journal-title":"Clin. Transl. Med."},{"key":"1301_CR179","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","volume":"3","author":"PJ Burke","year":"2017","unstructured":"Burke, P. J. Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer 3, 857\u2013870 (2017).","journal-title":"Trends Cancer"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01301-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:02:57Z","timestamp":1794574977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01301-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":179,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01301-y","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"4 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.C.W. is a consultant for Pano Therapeutics and Medical Excellence Capital. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}